hillparker

hillparker

Guest

hillparker815@gmail.com

  Raloxifene: A Promising Solution for Breast Cancer -Dosepharmacy (57 views)

8 Aug 2024 16:44

<p dir="ltr" style="line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;">[size= 12pt; font-family: Arial,sans-serif; color: #000000; background-color: #ffffff; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap]Buy Raloxifene, a selective estrogen receptor modulator (SERM), is emerging as a promising solution for breast cancer prevention and treatment. Initially used to combat osteoporosis, raloxifene's ability to block estrogen effects in breast tissue has proven beneficial in reducing the risk of hormone receptor-positive breast cancer, particularly in postmenopausal women. Clinical studies, such as the STAR trial, have demonstrated raloxifene's efficacy in lowering invasive breast cancer risk, with fewer side effects compared to Tamoxifen, another well-known SERM. Its mechanism involves binding to estrogen receptors, thereby inhibiting estrogen-driven cancer cell proliferation. For women at high risk of breast cancer due to genetic factors or family history, raloxifene offers a proactive preventive measure. As research continues to explore its full potential and optimize its application, raloxifene stands out as a key player in the fight against breast cancer, offering hope for improved outcomes and enhanced quality of life.[/size]

<span id="docs-internal-guid-d609642a-7fff-3cc1-6e6a-b19daea543f5">






</span>

49.43.33.116

hillparker

hillparker

Guest

hillparker815@gmail.com

Post reply
CAPTCHA Image
Powered by MakeWebEasy.com
This website uses cookies for best user experience, to find out more you can go to our Privacy Policy  and  Cookies Policy